Clinical trial
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of…
NCT00174473 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174473 |
|---|---|
| Title | A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children |
| Official title | An Open-label, Intravenous to Oral Switch, Multiple Dose Multi-Centre Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Hospitalized Children Aged 2 to 12 Years Who Require Treatment for the Prevention of Systemic Fungal Infections. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Neutropenia |
| Intervention type | Drug |
| Interventions | Voriconazole |
| Enrollment | 49 |
| Start date | Jun 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 10, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: